Inhibrx Biosciences (INBX) Operating Expenses (2023 - 2026)
Inhibrx Biosciences (INBX) recorded Operating Expenses of $32.15 million in Q2 2026, up 12.1% from $28.69 million a year earlier.
Powered by 
Analysis
Inhibrx Biosciences (INBX) Operating Expenses (2023 - 2026) Analysis & Trends
On a TTM basis, Inhibrx Biosciences' Operating Expenses came in at $125.57 million as of Jun 30, 2026, down 25.4% year-over-year; for FY2025, it was $136.33 million, down 58.9% from FY2024.
- Across earlier years, Operating Expenses came in at $331.65 million in FY2024 (+50.1%) and $221.02 million in FY2023.
- Quarterly Operating Expenses has ranged from $28.69 million in Q2 2025 to $161 million in Q2 2024 over the past five years.
- On a year-over-year basis, Operating Expenses rose in two of the last seven quarters, with an average decline of 31.5%.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 289.2% in Q2 2024, against a decline of 82.2% in Q2 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 10.12 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Inhibrx Biosciences | 1.54 Bn | 937.90 Mn | - | 32.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.15 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 33.81 Mn |
| Jun 30, 2025 | 28.69 Mn |
| Mar 31, 2025 | 42.90 Mn |
| Dec 31, 2024 | 50.03 Mn |
| Sep 30, 2024 | 46.80 Mn |
| Jun 30, 2024 | 161.00 Mn |
| Mar 31, 2024 | 73.83 Mn |
| Dec 31, 2023 | 89.92 Mn |
| Sep 30, 2023 | 45.95 Mn |
| Jun 30, 2023 | 41.37 Mn |
API Access
Inhibrx Biosciences Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=INBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "INBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=INBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();